Literature DB >> 6186642

Exogenous selenium in the brain. A histochemical technique for light and electron microscopical localization of catalytic selenium bonds.

G Danscher.   

Abstract

Transcardial perfusion or intraperitoneal injections with sodium selenite result in the creation of selenium bonds that can be visualized by physical development. The present paper describes how these catalytic bonds are made visible in the tissues by surrounding them with shells of metallic silver. Based on experiments with chelating agents, the possibility that selenium-metal bonds are the catalysts is discussed. In the brain, the selenium pattern is delicate and highly laminated, the grains of silver being orderly arranged corresponding with the neuropil morphology. The precipitate is most densely packed in cortical regions. The difference in staining intensity seen in different regions of the CNS reflects the density of selenium reactive terminals. The visualized selenium bonds are predominantly located within boutons, and examination in the electron microscope reveals accumulation in the presynaptic regions. In a few places precipitates can also be found in axons, but have not been observed in perikarya or dendrites. The only non-neuronal locations of selenium were sparsely scattered, astrocyte-like neuroglia, predominantly found in the cerebellum and the hypothalamus; infrequently a few blood vessels were also stained. Sections from kidney and liver are presented as examples of localizations outside the CNS of exogenous selenium.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6186642     DOI: 10.1007/bf00543951

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  16 in total

1.  METABOLISM OF DISULFIRAM AND DIETHYLDITHIOCARBAMATE IN RATS WITH DEMONSTRATION OF AN IN VIVO ETHANOL-INDUCED INHIBITION OF THE GLUCURONIC ACID CONJUGATION OF THE THIOL.

Authors:  J H STRUME
Journal:  Biochem Pharmacol       Date:  1965-04       Impact factor: 5.858

2.  Toxicology of selenium and tellurium and their compounds.

Authors:  E A CERWENKA; W C COOPER
Journal:  Arch Environ Health       Date:  1961-08

3.  Toxicology of non-radioactive heavy metals and their salts.

Authors:  B Venugopal; T P Luckey
Journal:  Environ Qual Saf Suppl       Date:  1975

Review 4.  Metabolic aspects of selenium action and toxicity.

Authors:  A T Diplock
Journal:  CRC Crit Rev Toxicol       Date:  1976-02

5.  Trimethyl selenide. A urinary metabolite of selenite.

Authors:  J L Byard
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

6.  Identification of a major selenium excretory product in rat urine.

Authors:  I S Palmer; D D Fischer; A W Halverson; O E Olson
Journal:  Biochim Biophys Acta       Date:  1969-04-01

7.  Selenotrisulfides. II. Cross-linking of reduced pancreatic ribonuclease with selenium.

Authors:  H E Ganther; C Corcoran
Journal:  Biochemistry       Date:  1969-06       Impact factor: 3.162

8.  Are selenocystine and selenomethionine synthesized in vivo from sodium selenite in mammals?

Authors:  L M Cummins; J L Martin
Journal:  Biochemistry       Date:  1967-10       Impact factor: 3.162

9.  Argyria-tissue deposition of silver as selenide.

Authors:  J Aaseth; A Olsen; J Halse; T Hovig
Journal:  Scand J Clin Lab Invest       Date:  1981-05       Impact factor: 1.713

Review 10.  Selenium biochemistry.

Authors:  T C Stadtman
Journal:  Science       Date:  1974-03-08       Impact factor: 47.728

View more
  53 in total

1.  Expression of the transcription factor, tailless, is required for formation of superficial cortical layers.

Authors:  P W Land; A P Monaghan
Journal:  Cereb Cortex       Date:  2003-09       Impact factor: 5.357

2.  Postnatal development of zinc-containing cells and neuropil in the visual cortex of the mouse.

Authors:  B Garrett; L Slomianka
Journal:  Anat Embryol (Berl)       Date:  1992-10

3.  Sequential phases of cortical specification involve Neurogenin-dependent and -independent pathways.

Authors:  Carol Schuurmans; Olivier Armant; Marta Nieto; Jan M Stenman; Olivier Britz; Natalia Klenin; Craig Brown; Lisa-Marie Langevin; Julie Seibt; Hua Tang; James M Cunningham; Richard Dyck; Christopher Walsh; Kenny Campbell; Franck Polleux; François Guillemot
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

4.  Kinetic and mutational analysis of Zn2+ modulation of recombinant human inhibitory glycine receptors.

Authors:  B Laube; J Kuhse; H Betz
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

5.  Densitometric analysis of the local bleaching of the Neo-Timm staining pattern following intrahippocampal injection of diethyldithiocarbamate.

Authors:  I E Holm; A Andreasen; G Danscher; H Nielsen
Journal:  Histochem J       Date:  1991-02

Review 6.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

7.  The autometallographic zinc-sulphide method. A new approach involving in vivo creation of nanometer-sized zinc sulphide crystal lattices in zinc-enriched synaptic and secretory vesicles.

Authors:  G Danscher
Journal:  Histochem J       Date:  1996-05

8.  Chemical blocking of zinc ions in CNS increases neuronal damage following traumatic brain injury (TBI) in mice.

Authors:  Peter Doering; Meredin Stoltenberg; Milena Penkowa; Jørgen Rungby; Agnete Larsen; Gorm Danscher
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

9.  Architectonic subdivisions of neocortex in the gray squirrel (Sciurus carolinensis).

Authors:  Peiyan Wong; Jon H Kaas
Journal:  Anat Rec (Hoboken)       Date:  2008-10       Impact factor: 2.064

10.  Exercise-induced motor improvement after complete spinal cord transection and its relation to expression of brain-derived neurotrophic factor and presynaptic markers.

Authors:  Matylda Macias; Dorota Nowicka; Artur Czupryn; Dorota Sulejczak; Małgorzata Skup; Jolanta Skangiel-Kramska; Julita Czarkowska-Bauch
Journal:  BMC Neurosci       Date:  2009-12-04       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.